Increase of CSF Inflammatory Profile in a Case of Highly Active Multiple Sclerosis

BMC Neurology - United Kingdom
doi 10.1186/s12883-019-1455-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Cladribine for Highly Active Relapsing Multiple Sclerosis

Prescriber
Pharmacology
2018English

Natalizumab Therapy for Highly Active Pediatric Multiple Sclerosis

JAMA Neurology
Neurology
2013English

A Case of Multiple Sclerosis Presenting With Inflammatory Cortical Demyelination

Neurology
Neurology
2011English

Alemtuzumab Following Natalizumab in Highly Active Paediatric-Onset Multiple Sclerosis

Multiple Sclerosis Journal - Experimental, Translational and Clinical
2019English

Cost Assessment Modelling of Treatments for Highly Active Relapsing Multiple Sclerosis

Advances in Therapy
MedicinePharmacology
2019English

Pnd26 - Cost Implications of a Novel Weight Dosed Treatment for Highly Active Relapsing Multiple Sclerosis in Portugal

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

CSF Β-Amyloid Predicts Prognosis in Patients With Multiple Sclerosis

Multiple Sclerosis
Neurology
2018English

A Case Report of Spinal Multiple Sclerosis

Journal of Medical Science And clinical Research
2018English

Change in Disability Profile and Quality of Life in Multiple Sclerosis Patients: A Five-Year Longitudinal Study Using the Multiple Sclerosis Impact Profile (MSIP)

Multiple Sclerosis
Neurology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy